Tag: Moderna RSV

As the year 2025 unfolds, new vaccines and treatments continue to transform the landscape of infectious disease prevention. One of the most notable recent advancements is Moderna’s RSV booster, developed to protect vulnerable populations from respiratory syncytial virus (RSV) — a significant cause of respiratory illness in infants, the elderly, and immunocompromised individuals. At the […]